Navigation Links
Dermatologists Can Help Women Win the Fight Against Common Forms of Hair Loss
Date:3/4/2010

e cases, Dr. Mercurio explained that a hormonal abnormality, such as excess male hormones known as androgens, may be responsible for hair loss in women. One clue that hormones are involved is if the hair loss pattern resembles that of a man's hair loss. While female-pattern hair loss caused by a hormonal imbalance can be treated with prescription medications such as spironolactone or oral contraceptives, it is important that women see their dermatologist for proper diagnosis and treatment.

Dr. Mercurio added that another treatment option to correct hair loss is hair transplantation, in which tiny hair follicles taken from one area of the scalp are transplanted into the affected areas. This surgical approach to restoring lost hair can be very effective and produce permanent results that are natural looking.

"I would urge women who are considering hair restoration surgery to find a dermatologist who is very experienced with hair transplants for women, and as a result, will be more aware of the nuances of female hair loss," said Dr. Mercurio.

Hyperandrogenism: Getting to the Root of this M
'/>"/>

SOURCE American Academy of Dermatology
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine news :

1. Dermatologists identify North Texas leishmaniasis outbreak
2. Dermatologists Warn Fitness Enthusiasts: Dont Let Exercise-Related Skin Problems Outweigh the Benefits of Physical Activity
3. Dont Pout About Irritated Lips: Dermatologists Can Offer Top Tips to Help Keep Lips in Tip-Top Shape
4. Dont Let Hair Loss Tangle You Up: Dermatologists Can Identify Common Hair Disorders and Offer Solutions
5. New Technology and Improved Techniques Arm Dermatologists With Tools to Minimize Facial Scars From Skin Cancer Surgery
6. New Studies Support Dermatologists Recommendation: Self-Exams, Screenings Vital for Detecting Skin Cancer
7. New Jersey Dermatologists Gear Up for Fifth Season of Play Safe in the Sun at LPGAs Sybase Classic to Urge Outdoor Enthusiasts to Protect Skin
8. Dermatologists Release Psoriasis Care Guidelines
9. Maryland Dermatologists Set New Records in Sun Safety Outreach at Popular LPGA Tournament
10. Dermatologists In Denial: Controversial New Chocolate Nutraceutical Claims to be Good for Your Skin
11. American Academy of Dermatology: Dermatologists Warn Ceramic Flat Irons Could Damage Hair and Lead to Hair Breakage
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/28/2014)... (PRWEB) November 28, 2014 Earlier ... reported during the hugely popular, 2014 MTV Video ... organization Truth launched ground-breaking celebrity centered television advertisements ... MTV viewership figures were estimated by Entertainment ... ads placed the spotlight on celebrities photographed by ...
(Date:11/28/2014)... New York (PRWEB) November 28, 2014 ... http://www.consumerinjurylawyers.com/stryker-rejuvenate/stryker-hip-lawsuits/ ) have now been filed in a ... recalled metal implants, Bernstein Liebhard LLP reports. ... in Bergen County Superior Court reflects the filing ... II modular-neck hip stems, which were voluntarily recalled ...
(Date:11/28/2014)... a leader in the wig industry, has announced a great ... promotion features: , > 400 pieces of FOUR ... (no coupon code needed), > 10% off for ... $49 , Visit http://www.uniwigs.com for more details , The ... 1st and the first 100 shoppers each day will receive our ...
(Date:11/28/2014)... November 28, 2014 Patten Pecans, based ... grown. With those passions driving them, they've added a ... Having tried other pecans oils, they've found this ... to be exceptionally flavorful, retaining the buttery pecan notes ... nutritional benefits found in pecans nuts is ...
(Date:11/28/2014)... 28, 2014 An inventor from Flint, Mich., ... day. "I got this idea while lying in a hospital ... he said. , The Bed Buddy provides a more ergonomic ... the bathroom. It eliminates the need to leave the bed, ... and dignity. Easy to use and producible in design variations, ...
Breaking Medicine News(10 mins):Health News:Freedom Laser Therapy Applauds American Legacy’s Creative Advertising Targeting Celebrity Smokers 2Health News:Freedom Laser Therapy Applauds American Legacy’s Creative Advertising Targeting Celebrity Smokers 3Health News:Freedom Laser Therapy Applauds American Legacy’s Creative Advertising Targeting Celebrity Smokers 4Health News:Freedom Laser Therapy Applauds American Legacy’s Creative Advertising Targeting Celebrity Smokers 5Health News:More than 2,100 Stryker Hip Lawsuits Included in New Jersey Litigation after Settlement Announcement, Bernstein Liebhard LLP Reports 2Health News:More than 2,100 Stryker Hip Lawsuits Included in New Jersey Litigation after Settlement Announcement, Bernstein Liebhard LLP Reports 3Health News:Pre-X'mas Crazy Sale Starts from $0 at UniWigs.com 2Health News:Patten Pecans Goes Local with Nutritious Georgia Pecan Oil 2
... Carson M.D., professor of medicine and director of the Rebecca ... California, San Diego (UCSD) has identified a potent new anti-cancer ... South Pacific. The properties of somocystinamide A (ScA) are ... Proceedings of the National Academy of Science the week of ...
... A University of Alberta study recommends that workers on pig ... a child on a communal farm in Canada was diagnosed ... made a full recovery, health researchers were concerned because of ... multi-family community, who, fortunately, all demonstrated mild or no apparent ...
... $1 million, Five-year Grant, from New York State Department ... Becomes Lead,Poisoned, NEW YORK, Feb. 11 The ... at Montefiore,(CHAM) has been named one of three State ... regional healthcare delivery for children and,pregnant women with elevated ...
... lead to less controversial method of treating diseases , , ... they,ve reprogrammed human skin cells into ones with the ... that could aid in treating many diseases while sidestepping ... to become every cell type found in the human ...
... Inc.,(Nasdaq: NXXI ), the developer and marketer ... Iceland Health(R) brands that,help consumers manage blood sugar ... joint pain, today announced financial,results for the second ... 2007., The Company reported a 43% increase ...
... Feb. 11 Lincare Holdings,Inc. (Nasdaq: LNCR ), ... delivered to patients in the home, today announced,financial results ... 2007., For the quarter ended December 31, 2007, ... $368.1 million for the fourth quarter of,2006. The Company ...
Cached Medicine News:Health News:UCSD research team identifies novel anticancer drug from the sea 2Health News:Swine flu monitoring needed for farm workers, study says 2Health News:Montefiore Lead Poisoning Prevention ProgramNamed One of Three State Regional Resource Centers 2Health News:Scientists Reprogram Human Skin Cells Into Embryonic Stem Cells 2Health News:Scientists Reprogram Human Skin Cells Into Embryonic Stem Cells 3Health News:Nutrition 21 Reports Fiscal Second Quarter 2008 Financial Results 2Health News:Nutrition 21 Reports Fiscal Second Quarter 2008 Financial Results 3Health News:Nutrition 21 Reports Fiscal Second Quarter 2008 Financial Results 4Health News:Nutrition 21 Reports Fiscal Second Quarter 2008 Financial Results 5Health News:Nutrition 21 Reports Fiscal Second Quarter 2008 Financial Results 6Health News:Nutrition 21 Reports Fiscal Second Quarter 2008 Financial Results 7Health News:Lincare Holdings Inc. Announces Fourth Quarter and Year Ended 2007 Financial Results 2Health News:Lincare Holdings Inc. Announces Fourth Quarter and Year Ended 2007 Financial Results 3Health News:Lincare Holdings Inc. Announces Fourth Quarter and Year Ended 2007 Financial Results 4Health News:Lincare Holdings Inc. Announces Fourth Quarter and Year Ended 2007 Financial Results 5Health News:Lincare Holdings Inc. Announces Fourth Quarter and Year Ended 2007 Financial Results 6Health News:Lincare Holdings Inc. Announces Fourth Quarter and Year Ended 2007 Financial Results 7
(Date:11/26/2014)... 2014   Heska Corporation (NASDAQ: HSKA ... provider of advanced veterinary diagnostic and other specialty veterinary ... Chair, will attend The Benchmark Company, LLC,s Micro Cap Discovery ... be held at The Palmer House Hilton, 17 E. Monroe ... to 2:30 p.m. Please email hska@haydenir.com or contact ...
(Date:11/26/2014)... , Nov. 25, 2014  Array ... today announced that its Chief Executive Officer, ... the following upcoming conferences.  The public is ... webcasts on the Array BioPharma website:  ... 3, 2014Time:1:30 p.m.  Eastern Time Location: Palace ...
(Date:11/26/2014)... and LONDON , Nov. 25, 2014 /PRNewswire/ ... AZN ) today announced that AMAGINE-2 TM , ... brodalumab in more than 1,800 patients with moderate-to-severe plaque psoriasis, ... (ustekinumab) and placebo at week 12. Brodalumab 210 mg ... were each shown to be superior to Stelara on the ...
Breaking Medicine Technology:Heska to Attend Benchmark Micro Cap Discovery Conference 2Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 2Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 3Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 4Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 5Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 6Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 7Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 8Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 9Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 10
... SAN FRANCISCO, Calif., May 16, 2012  Rigel Pharmaceuticals, Inc., ... franchise by focusing on two innovative, comprehensive treatment alternatives ... an inhaled SYK inhibitor, will be entering a Phase ... moderate asthmatic patients. The other, R256, an inhaled IL13 ...
... May 15, 2012   OphthaliX (OTCBB: OPLI) today ... ended March 31, 2012. OphthaliX is an advanced clinical-stage ... treatment of ophthalmic disorders.  Our drug, CF101 (known generically ... indications: dry eye syndrome; glaucoma and uveitis. We are ...
Cached Medicine Technology:Rigel Advances Asthma Programs: Two Inhaled Drug Candidates Take Aim at Acute and Chronic Lung Disease 2Rigel Advances Asthma Programs: Two Inhaled Drug Candidates Take Aim at Acute and Chronic Lung Disease 3Rigel Advances Asthma Programs: Two Inhaled Drug Candidates Take Aim at Acute and Chronic Lung Disease 4OphthaliX Reports First Quarter 2012 Financial Results 2OphthaliX Reports First Quarter 2012 Financial Results 3
S-ROM acetabular cups provide a variety of geometrical options to help address many anatomical situations and defects....
Duraloc acetabular cup system....
... acetabular cup system has been designed to ... tri-spiked and cluster hole configurations. The objective ... micromotion on three primary modes: Tilt, migration ... features result in initial and long-term fixation. ...
Biopro rimmed acetabular is manufactured from titanium and is porous coated on the outside of its shell. The rimmed acetabular accommodates a polyethylene inert....
Medicine Products: